The market was valued at US$ 15.59 billion in 2022 and is expected to reach US$ 25.14 billion by 2030; it is estimated to record a CAGR of 6.2% during 2022-2030.

Kidney dialysis equipment is used to treat patients with chronic kidney conditions. The equipment includes a dialyzer that filters out waste products and excess blood fluids when kidneys fail to perform adequately.

Market Drivers Affecting Kidney Dialysis Equipment Market

Kidney failure has emerged as one of the most prominent causes of death in recent times. As per an article published in ScienceDirect in April 2022, CKD is a progressive disease affecting over 10% of the population worldwide, representing over 800 million individuals. As people age, they become more susceptible to renal illnesses due to age-related conditions such as hypertension and diabetes. Dialysis is a life-saving treatment that helps eliminate excess fluid and waste products from the blood when the kidneys can't function properly. Dialysis equipment is required to manage patients with impaired kidney function. With the increase in the aging population worldwide and the burgeoning number of patients diagnosed with CKD or end-stage renal disease (ESRD), the demand for dialysis equipment such as hemodialysis machines, dialyzers, and dialysis concentrate is expected to rise significantly. Thus, the increasing prevalence of CKD, driven by determinants such as hypertension, obesity, diabetes, and an aging population, bolsters the kidney dialysis equipment market size 2022-2030.

Emerging Market Trends:

Machine design and technology advancements allow manufacturers to develop innovative and efficient dialysis equipment. The modern equipment offerings confer better patient comfort, improved treatment results, and reduced treatment time. The use of sterilizing technologies, disposable dialyzers, and improved water purification systems in dialysis equipment helps lower the risk of infections. Additionally, there has been a shift toward home-based dialysis treatments, leading to a rise in the demand for portable and wearable dialysis machines. A greater number of digital technology firms are entering the healthcare sector to help improve accessibility to dialysis equipment, particularly for the remote treatment of renal disorders. For instance, in June 2023, AWAK Technologies collaborated with Singapore General Hospital (SGH) to launch a pre-pivotal clinical trial of an automated wearable artificial kidney peritoneal dialysis (AWAK PD) device. AWAK PD is a wearable and ultra-portable system that enables healthcare providers to facilitate the dialysis of patients with end-stage kidney disease at their homes or any place of their comfort. In March 2021, Fresenius Medical Care North America (FMCNA) and DaVita Kidney Care expanded their agreement to provide home dialysis solutions in the US. This product line includes NxStage home hemodialysis (HHD) machines, dialysis supplies, and a connected health platform. The agreement is aimed at empowering more chronic kidney failure patients to opt for home dialysis, which can improve their quality of life.

Therefore, such modern dialysis technologies are expected to bring new kidney dialysis equipment market trends in the coming years.

Kidney Dialysis Equipment Market Analysis based on the Segmental Share:

Based on product, the market is subsegmented into cholinesterase inhibitors, NMDA receptor antagonists, combination drugs, and pipeline drugs. The cholinesterase inhibitors segment accounted for the largest Alzheimer's drugs market share in 2022 and is estimated to register the highest CAGR during 2022-2030. Based on product, the cholinesterase inhibitors segment is further segmented into Donepezil, Galantamine, and Rivastigmine. Cholinesterase inhibitors are prescribed by specialists such as psychiatrists or neurologists for early- to mid-stage AD. These drugs boost the levels of acetylcholine in the brain, a neurotransmitter that helps nerve cells communicate with each other.

The market is segmented by distribution channel into hospital pharmacies, retail pharmacies, and online pharmacies. In 2022, the hospital pharmacies segment held the largest market share. Online pharmacies segment is anticipated to register the highest CAGR during 2022-2030.

Regional Kidney Dialysis Equipment Market Analysis:

North America held the largest kidney dialysis equipment market share in 2022. The US held the largest market share in this region in 2022, followed by Canada, owing to the increasing prevalence of CKD among people in the region. According to the National Health Institute of Diabetes and Digestive and Kidney Diseases, in 2021, over 37 million adults in the US were affected by CKD. ~808,000 Americans were living with ESKD in 2020, out of which 69% were on dialysis and 31% underwent a kidney transplant. Other factors propelling North America's kidney dialysis equipment market growth include the introduction of advanced equipment in healthcare, a rising number of hospitals, increasing healthcare expenditures, and the implementation of strategic policies by governments.